Linked from

The 44 pages that link to Renin–angiotensin–aldosterone system, each with the reason it gives.

• AldosteroneNarrower topic: This system is a major controller of aldosterone secretion when kidney perfusion or sodium delivery falls.

• ACE inhibitorNarrower topic: ACE inhibitors interrupt this system between angiotensin I and angiotensin II.

• Angiotensin-converting enzymeNarrower topic: ACE is a key step in the system’s production of angiotensin II.

• Primary aldosteronismNarrower topic: Primary aldosteronism disrupts its usual renin control of aldosterone.

• Angiotensin IINarrower topic: Angiotensin II is its principal vasoconstrictor and aldosterone-stimulating effector.

• SpironolactoneNarrower topic: Aldosterone, the hormone spironolactone opposes, is the system’s downstream effector.

• CaptoprilNarrower topic: Captopril acts within this system by preventing angiotensin II formation.

• Sacubitril/valsartanNarrower topic: Valsartan counteracts a pathway that can worsen heart failure through vasoconstriction and fluid retention.

• LisinoprilNarrower topic: Lisinopril alters this system’s signaling to reduce vascular constriction and fluid retention.

• LosartanNarrower topic: Losartan interrupts one of this system’s main blood-pressure pathways.

• Angiotensin INarrower topic: Angiotensin I is a short-lived intermediate in this regulatory network.

• EnalaprilNarrower topic: Enalapril changes blood pressure by interrupting this regulatory pathway.

• ValsartanNarrower topic: Valsartan acts on this system's signaling pathway to reduce vascular and hormonal pressure effects.

• RamiprilNarrower topic: Ramipril interrupts one of this system’s main pathways for raising blood pressure.